Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Brock O Neil"'
Autor:
Daniel D. Joyce, Michael Goodman, Antoinette M. Stroup, Xiao-Cheng Wu, Mia Hashibe, Ann S. Hamilton, Amy N. Luckenbaugh, Zhiguo Zhao, Tatsuki Koyama, Christopher J.D. Wallis, Matthew R. Cooperberg, Sherrie H. Kaplan, Li-Ching Huang, Daniel A. Barocas, Karen E. Hoffman, Ralph Conwill, David F. Penson, Brock O' Neil, Lisa E. Paddock, Heather L. Huelster, Sheldon Greenfield
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:238-247
Sexual dysfunction, including erectile dysfunction and loss of libido, are common among men undergoing treatment for localized prostate cancer. Both local treatments and systemic androgen deprivation therapy may contribute to these outcomes and are d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add1d1d5f70e1999fa9467a368b2d32c
https://doi.org/10.1038/s41391-021-00405-5
https://doi.org/10.1038/s41391-021-00405-5
Autor:
Stacey Slager, Vickie Venne, Susan Zickmund, Benjamin L. Maughan, Samantha Greenberg, Nicole Stopa, Kathleen A. Cooney, Brock O' Neil, Sarah Colonna
Publikováno v:
The Prostate. 80:441-450
BACKGROUND Guidelines have changed recently to include genetic counseling (GC) and/or genetic testing (GT) for all men with aggressive prostate cancer (PCa). This study aimed to identify what information men with PCa desire before and from GC. METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422babd49b45d1ec0052b7fd9108f0dc
https://doi.org/10.1002/pros.23959
https://doi.org/10.1002/pros.23959
Comparing pretest video genetic education for prostate cancer patients: Do patients need assistance?
Autor:
Samantha Greenberg, Elizabeth Orlando, Morgan Devlin, Sara Low, Amanda Anson, Brock O Neil, Wendy Kohlmann, Bob Wong, Christopher B. Dechet, Alejandro Sanchez, Jonathan David Tward, Skyler B Johnson, Neeraj Agarwal, Manish Kohli, Sumati Gupta, Umang Swami, Benjamin L. Maughan
Publikováno v:
Journal of Clinical Oncology. 40:5061-5061
5061 Background: Expanded germline genetic testing recommendations for individuals with prostate cancer (PCa) have resulted in increased demand for pre-test genetic education. As a result, alternative service delivery models in genetic counseling (GC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8ae9912e0876ed97fb42b049ba06fff
https://doi.org/10.1200/jco.2022.40.16_suppl.5061
https://doi.org/10.1200/jco.2022.40.16_suppl.5061
Autor:
Emily Moody, McCall Larson, Samantha Greenberg, Taylor Jump, Mckenzie Bell, Jesse Gygi, Lisa Garcia, Desiree Dougherty, Brock O Neil, Steven C Lynch, Derrick S. Haslem, David Michael Gill
Publikováno v:
Journal of Clinical Oncology. 40:59-59
59 Background: Guidelines recommend germline genetic not only for men with advanced and metastatic prostate cancer but also those with NCCN-high risk disease. Many men harboring germline DNA repair defects would not have met criteria for testing unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42421985dd98c51803f87354f2200042
https://doi.org/10.1200/jco.2022.40.6_suppl.059
https://doi.org/10.1200/jco.2022.40.6_suppl.059
Autor:
Sumati Gupta, G. Daniel Grass, Benjamin L. Maughan, Rohit K. Jain, Christopher B. Dechet, Alejandro Sanchez, Brock O Neil, Michael Adam Poch, Roger Li, Shane Lloyd, Jonathan David Tward, Tenzin Kunsang Phunrab, Josiah Hawks, Umang Swami, Kenneth M Boucher, Neeraj Agarwal
Publikováno v:
Journal of Clinical Oncology. 40:506-506
506 Background: Nivolumab has known efficacy as adjuvant therapy after radical cystectomy in localized muscle invasive bladder cancer (MIBC). We are evaluating the efficacy of nivolumab adjuvant to definitive chemo-radiation therapy (CRT) in MIBC. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db1bc1f5ce4c0c70d552c029438a775b
https://doi.org/10.1200/jco.2022.40.6_suppl.506
https://doi.org/10.1200/jco.2022.40.6_suppl.506
Autor:
Jeffrey Vehawn, Mouneeb Choudry, Trevor Charles Hunt, Christopher Martin, Jacob P. Ambrose, Benjamin Haaland, Jonathan Chipman, Heidi A. Hanson, Brock O Neil
Publikováno v:
Journal of Clinical Oncology. 40:25-25
25 Background: Previous studies have shown that individuals with cancer who live in rural areas have worse cancer-specific outcomes compared to their urban counterparts. Differences in access to high-quality cancer care and adequate social support ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64852d17aa44f0ff6445bb3ba037e9b8
https://doi.org/10.1200/jco.2022.40.6_suppl.025
https://doi.org/10.1200/jco.2022.40.6_suppl.025
Autor:
Jeffrey Vehawn, Suzanne Lange, Mouneeb Choudry, Jacob P. Ambrose, Benjamin Haaland, Niraj Paudel, Heidi A. Hanson, Brock O Neil
Publikováno v:
Journal of Clinical Oncology. 40:240-240
240 Background: Debate remains about the value of Prostate-specific antigen (PSA) based prostate cancer screening among men aged 55-69 (USPSTF Grade C). However, no professional society or guideline recommends PSA based prostate cancer screening in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad34c04dcfe980ba0fa38a9b9772f25e
https://doi.org/10.1200/jco.2022.40.6_suppl.240
https://doi.org/10.1200/jco.2022.40.6_suppl.240
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Evolving research suggests that up to 12% of metastatic prostate cancer (PC) cases are attributable to hereditary cancer risk. Targeted therapy may be suitable for some ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca674c71256bf7eadbd54cdad2f2bb2
https://doi.org/10.1097/01.ju.0000556119.22008.cc
https://doi.org/10.1097/01.ju.0000556119.22008.cc
Autor:
Amy M Cizik, Christina Sossenheimer, Brock O' Neil, Christopher Dechet, Jonathan D. Tward, Sara M. Lenherr, Alejandro Sanchez
Publikováno v:
Journal of Clinical Oncology. 39:e18614-e18614
e18614 Background: To examine the relationship between neoadjuvant chemotherapy (NAC) clinical risk factors, and patient reported quality of life in patients with MIBC undergoing cystectomy. Methods: cT2-T4, N0, M0 MIBC patients who underwent radical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48eb2bd99f03dea2323626afb7a7b60d
https://doi.org/10.1200/jco.2021.39.15_suppl.e18614
https://doi.org/10.1200/jco.2021.39.15_suppl.e18614
Autor:
Siamak Daneshmand, Sara Lewis, Anishka D'souza, Tanya B. Dorff, Kevin Chan, Jeremy Cetnar, Matthew D. Galsky, Sumanta K. Pal, Sudeh Izadmehr, John P. Sfakianos, Menggang Yu, Brock O Neil, Reza Mehrazin, Philip Garcia, Qianqian Zhao, Christos Kyriakopoulos, Ronac Mamtani
Publikováno v:
Journal of Clinical Oncology. 39:4503-4503
4503 Background: Transurethral resection of bladder tumor (TURBT) plus systemic therapy has been known for decades to achieve durable bladder-intact survival in a subset of patients with MIBC but efforts to advance this paradigm have been complicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5d767624a9bf332974fe225707aac92
https://doi.org/10.1200/jco.2021.39.15_suppl.4503
https://doi.org/10.1200/jco.2021.39.15_suppl.4503